240 related articles for article (PubMed ID: 21401493)
1. Adenosine and related drugs in brain diseases: present and future in clinical trials.
Lopes LV; Sebastião AM; Ribeiro JA
Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
[TBL] [Abstract][Full Text] [Related]
2. Modulators of nucleoside metabolism in the therapy of brain diseases.
Boison D
Curr Top Med Chem; 2011; 11(8):1068-86. PubMed ID: 21401494
[TBL] [Abstract][Full Text] [Related]
3. The role of adenosine in the regulation of sleep.
Huang ZL; Urade Y; Hayaishi O
Curr Top Med Chem; 2011; 11(8):1047-57. PubMed ID: 21401496
[TBL] [Abstract][Full Text] [Related]
4. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
5. The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects.
Sperlágh B; Vizi ES
Curr Top Med Chem; 2011; 11(8):1034-46. PubMed ID: 21401497
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2A receptors and neuroprotection.
Ongini E; Adami M; Ferri C; Bertorelli R
Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
[TBL] [Abstract][Full Text] [Related]
7. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Structural Insight into Adenosine A
Karati D; Mukherjee S; Roy S
Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
[TBL] [Abstract][Full Text] [Related]
9. A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.
Gessi S; Merighi S; Stefanelli A; Fazzi D; Varani K; Borea PA
Pharmacol Res; 2013 Oct; 76():157-70. PubMed ID: 23969284
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.
Stockwell J; Jakova E; Cayabyab FS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28441750
[TBL] [Abstract][Full Text] [Related]
11. Research progress on adenosine in central nervous system diseases.
Liu YJ; Chen J; Li X; Zhou X; Hu YM; Chu SF; Peng Y; Chen NH
CNS Neurosci Ther; 2019 Sep; 25(9):899-910. PubMed ID: 31334608
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
Pagnussat N; Almeida AS; Marques DM; Nunes F; Chenet GC; Botton PH; Mioranzza S; Loss CM; Cunha RA; Porciúncula LO
Br J Pharmacol; 2015 Aug; 172(15):3831-45. PubMed ID: 25939452
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptors in the nervous system: pathophysiological implications.
Ribeiro JA; Sebastião AM; de Mendonça A
Prog Neurobiol; 2002 Dec; 68(6):377-92. PubMed ID: 12576292
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
[TBL] [Abstract][Full Text] [Related]
15. [Neuroprotective mechanisms of adenosine action on CNS neurons].
Zalewska-Kaszubska J
Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
[TBL] [Abstract][Full Text] [Related]
16. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
Rivera-Oliver M; Díaz-Ríos M
Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
18. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Giunta S; Andriolo V; Castorina A
Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
20. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois JM
Psychopharmacology (Berl); 2000 Feb; 148(2):153-63. PubMed ID: 10663430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
